CClinicalTrials.gg
Not yet recruitingNCT06166303Updated Aug 26, 2025

Number of Previous Cesarean Sections on the Results of Angiogenic Factors.

An observational study in Cesarean Section, sponsored by Saint Thomas Hospital, Panama. Not yet recruiting at 1 site in Panama. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-26.

Sponsored by Saint Thomas Hospital, Panama · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
540
Ages
18 Years and older
Sex
Female
01

Study summary

Hypertensive disorders of pregnancy (HPT) are an important cause of maternal-feto-neonatal morbidity and mortality, being one of the three leading causes of maternal death in our country and in developing countries. The only cure for THE is termination of pregnancy, which ends up being a decision in which gestational age and maternal risks must be balanced. Angiogenic factors have come to occupy an indispensable place in the arsenal of tools that can be used to separate the patient with a high likelihood of complications from those in whom prolongation of pregnancy could represent an important neonatal benefit.

Although the usefulness of angiogenic factors in these scenarios is known, little is known about the effects that other conditions might have on their serum levels, mainly those that have an effect on trophoblastic invasion, the process that initiates implantation of the pregnancy in the endometrium. The purpose of the present study is to assess the effect that a history of uterine surgery, such as caesarean section, might have on angiogenic factor scores in subjects with no history of a hypertensive disorder of pregnancy.

02

Conditions studied

  • Cesarean Section

Browse trials for

Keywords

  • Cesarean section
  • Angiogenic factors
  • Preeclampsia
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Pregnant woman with a previous cesarean section

Inclusion criteria

  • 36 weeks of gestation or more
  • Singleton pregnancy
  • Previous cesarean section (case)

Exclusion criteria

Exclusion Criteria:

  • Vasculitis
  • Twin pregnancy
  • Chronic endometritis
  • Smoking
  • Lupus
  • Renal failure
  • Liver disease
  • Thrombocytopenia
04

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
540 participants (estimated)
Patient registry
No

Groups and cohorts

  • Previous Cesarean Section

    Subjects with one or more previous cesarean sections

    Diagnostic Test: sFlt-1/PGIF

  • No Cesarean

    Subjects scheduled for an elective or urgent cesarean, but no history of previous cesarean section

    Diagnostic Test: sFlt-1/PGIF

Interventions

  • Diagnostic testsFlt-1/PGIF

    Index of sFlt-1/PGIF

05

What researchers measure

Primary outcomes

  1. Index sFlt-1/PIGF

    Angiogenic factors, normal value.

    Time frame: From the moment of randomization up until delivery. Between 24-48 hours.

Secondary outcomes

  1. Progression to preeclampsia

    Number of subjects that develop a preeclampsia

    Time frame: Up until discharge. On average, 7 days

06

Study locations

1 site
  • Saint Thomas H
    Panama City, Provincia de Panamá, Panama
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06166303
Lead sponsor
Saint Thomas Hospital, Panama
Responsible party
Osvaldo A. Reyes T. (Head of the research deparment, Saint Thomas Hospital, Panama) — Principal investigator
First posted
Dec 12, 2023
Start date
Oct 1, 2025 (estimated)
Primary completion
Jan 30, 2026 (estimated)
Completion
Mar 30, 2026 (estimated)
Last update
Aug 26, 2025

Study contacts

Osvaldo Reyes, MD
Contact
oreyespanama@yahoo.es
+507 65655041
Osvaldo Reyes
principal investigator · Hospital Santo Tomás

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion